System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Emmanuel Mahé is an expert in Dermatology at Centre Hospitalier Victor Dupouy (France). As of October 2026, ScienceLeadR ranks Emmanuel Mahé in the top 1% of experts worldwide for Psoriasis, Sexually Transmitted Diseases and Skin Diseases, Papulosquamous. Emmanuel Mahé has authored 570 publications, the most recent in 2026, and is an investigator in 14 clinical trials, 5 of them ongoing. SLR score: 1,759 (community average: 125). How the SLR is computed.

LeadR Profile

Emmanuel Mahé Centre Hospitalier Victor Dupouy France
1 759 ScienceLeadR Reputation 1759

Unlock

Register Login
Network Map

Dermatology

Subspecialties: Pediatrics - Infectiology - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1988 - 2026
Source: PubMed

Versailles Saint-Quentin-en-Yvelines University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 570

Citations

Citations: 5 910 1st author: 116 Last author: 145 Unique author: 14

Main journals

Ann Dermatol Venereol 214
J Eur Acad Dermatol Venereol 46
Annales de dermatologie et de vénéréologie, FMC 32
Br J Dermatol 25
Annales de Dermatologie et de Vénéréologie - FMC 23

Best Journals

N Engl J Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Correction: Effectiveness and Safety of IL‑17A Inhibitors in Pediatric Psoriasis: A Real‑World, Multicenter, International Study.
PMID 42870136 — safety, pharmaceutical preparations, psoriasis		Paediatr Drugs20260
Molluscum Contagiosum, Warts and Condylomas during JAK Inhibitor Therapy for Atopic Dermatitis: a Retrospective Series of 17 Cases.
PMID 42862144 — sexually transmitted diseases, molluscum contagiosum, dermatitis, warts, therapeutics, janus kinase inhibitors, dermatology, dermatitis, atopic		Acta Derm Venereol20260
ADAR1 loss-of-function variants altering RNA editing define a new interferon-dependent psoriasis subtype.
PMID 42424135 — genes, rna editing, psoriasis, rna		J Exp Med20262
Pediatric Phthiriasis Palpebrarum: A French Multicentric Retrospective Study of 20 Cases.
PMID 42437072 — eyelids, retrospective studies, diagnosis, therapeutics, pediatrics, child abuse, child		J Pediatr Clin Pract20261
Can Systemic Treatment for Childhood Psoriasis Be Stopped in Cases of Remission? Data From the ACMe Cohort.
PMID 42409581 — skin diseases, cyclosporine, adolescent, therapeutics, psoriasis, acitretin, dermatology, methotrexate, child		Pediatr Dermatol20260

Clinical Studies 14

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

Phase 3 9
N/A 3
Phase 4 2

By status:

Completed 7
Recruiting 4
Active not recruiting 2
Unknown 1

By type:

Interventional 13
Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 1
multicentric5to9 2
multicentricup10 10

Main Topics

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A study to learn how bimekizumab works in children and teenagers with moderate to severe plaque psoriasis
2023-503859-10-00 — ustekinumab, safety, adolescent, psoriasis, child		Phase 3Active not recruiting2024
Randomized clinical trial to compare oral isotretinoin to standard of care in moderate acne skin of color patients
2023-507519-36-00 — isotretinoin, skin		Phase 3Recruiting2025
Assessment of the Effect of a Dermatology Oriented Spa Therapy on the Quality of Life of Patients With Psoriasis
NCT06735911 — quality of life, baths, inhalation, therapeutics, psoriasis, drinking, dermatology		N/ARecruiting2025
Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients
NCT06447480 — isotretinoin, skin, quality of life, doxycycline, adapalene, lymecycline, hyperpigmentation, acne vulgaris, therapeutics, pigmentation, tretinoin		Phase 3Recruiting2025
Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus
NCT05898308 — injections, skin, antibodies, adrenal cortex hormones, skin diseases, desmogleins, biomarkers, maintenance, rituximab, precision medicine, acantholysis, therapeutics, pemphigus		Phase 4Recruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS